United Capital Financial Advisors LLC Takes Position in Cencora, Inc. $COR

United Capital Financial Advisors LLC acquired a new stake in shares of Cencora, Inc. (NYSE:COR) in the second quarter, HoldingsChannel reports. The institutional investor acquired 8,387 shares of the company’s stock, valued at approximately $2,373,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in COR. Kemnay Advisory Services Inc. bought a new position in Cencora in the 4th quarter worth $25,000. Elyxium Wealth LLC purchased a new position in Cencora in the fourth quarter worth about $27,000. Archer Investment Corp increased its position in shares of Cencora by 134.3% during the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. Motiv8 Investments LLC bought a new stake in Cencora in the fourth quarter worth about $29,000. Finally, Basepoint Wealth LLC purchased a new position in Cencora during the 4th quarter valued at $32,000. Institutional investors own 97.52% of the company’s stock.

Cencora Trading Up 0.3%

NYSE COR opened at $322.12 on Friday. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54. The company has a fifty day simple moving average of $307.38 and a two-hundred day simple moving average of $310.88. The company has a current ratio of 0.93, a quick ratio of 0.58 and a debt-to-equity ratio of 3.53. The stock has a market cap of $61.47 billion, a P/E ratio of 23.93, a P/E/G ratio of 1.84 and a beta of 0.57.

Cencora (NYSE:COR) last issued its earnings results on Wednesday, August 5th. The company reported $4.48 EPS for the quarter, beating analysts’ consensus estimates of $4.35 by $0.13. The firm had revenue of $84.75 billion for the quarter, compared to analyst estimates of $84.31 billion. Cencora had a return on equity of 125.45% and a net margin of 0.79%.Cencora’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $4.00 earnings per share. On average, analysts forecast that Cencora, Inc. will post 17.87 earnings per share for the current year.

Cencora Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be issued a $0.60 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. Cencora’s dividend payout ratio is presently 17.83%.

Cencora declared that its board has approved a stock repurchase program on Thursday, May 21st that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the company to buy up to 3.9% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its shares are undervalued.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on COR shares. Morgan Stanley lifted their price objective on shares of Cencora from $342.00 to $346.00 and gave the company an “overweight” rating in a report on Friday, August 7th. Wells Fargo & Company raised their price objective on Cencora from $331.00 to $395.00 and gave the stock an “overweight” rating in a report on Tuesday, August 11th. UBS Group raised their price target on Cencora from $412.00 to $430.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Barclays dropped their target price on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a report on Wednesday, June 10th. Finally, Robert W. Baird set a $370.00 price objective on shares of Cencora in a research note on Thursday, August 6th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $370.85.

Insider Transactions at Cencora

In other news, EVP Elizabeth S. Campbell sold 11,300 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $324.12, for a total value of $3,662,556.00. Following the completion of the sale, the executive vice president directly owned 19,455 shares in the company, valued at $6,305,754.60. The trade was a 36.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Lauren M. Tyler acquired 550 shares of Cencora stock in a transaction on Monday, June 22nd. The shares were bought at an average price of $270.23 per share, with a total value of $148,626.50. Following the completion of the transaction, the director directly owned 4,359 shares of the company’s stock, valued at $1,177,932.57. This trade represents a 14.44% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.38% of the company’s stock.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.